International Gemmological Institute (India) Ltd. (IGIL.NS)
Mumbai, IN
Operating both within India and globally, International Gemmological Institute (India) Limited provides expert certification and authentication for natural and laboratory-created diamonds, alongside studded jewelry and colored gemstones. The organization's services further encompass diamond assessment, grading, and various complementary offerings. Additionally, its IGI Schools of Gemology deliver comprehensive educational programs and professional development training. Established in 1975 and headquartered in Mumbai, India, this entity functions as a division of BCP Asia II TopCo Pte. Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.87% | +14.46% | +6.79% | +12.71% | +16.12% | +11.04% | -0.95% | -21.04% | -21.04% | -21.04% | -21.04% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
10.64B
est.
|
12.29B
est: 12.09B (+1.6%)
|
14.60B
14.23B – 14.97B
+20.7% YoY
|
15.65B
14.89B – 16.42B
+7.2% YoY
|
17.08B
16.64B – 17.51B
+9.1% YoY
|
19.36B
18.86B – 19.85B
+13.3% YoY
|
| EBITDA |
6.77B
est.
|
7.83B
est: 7.70B (+1.6%)
|
9.30B
9.06B – 9.53B
+20.7% YoY
|
9.97B
9.48B – 10.45B
+7.2% YoY
|
10.88B
10.60B – 11.15B
+9.1% YoY
|
12.33B
12.01B – 12.64B
+13.3% YoY
|
| EBIT |
6.40B
est.
|
7.40B
est: 7.28B (+1.6%)
|
8.79B
8.57B – 9.01B
+20.7% YoY
|
9.42B
8.96B – 9.88B
+7.2% YoY
|
10.28B
10.02B – 10.54B
+9.1% YoY
|
11.65B
11.36B – 11.95B
+13.3% YoY
|
| Net Income |
4.55B
est.
|
5.32B
est: 5.45B (-2.5%)
|
6.34B
6.13B – 6.55B
+16.3% YoY
|
7.26B
7.02B – 7.49B
+14.4% YoY
|
8.84B
8.55B – 9.13B
+21.8% YoY
|
10.27B
9.93B – 10.61B
+16.2% YoY
|
| SGA |
—
est.
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
10.15
est.
|
12.30
est: 12.15 (+1.2%)
|
14.13
13.67 – 14.60
+16.3% YoY
|
16.17
15.64 – 16.71
+14.4% YoY
|
19.70
19.05 – 20.35
+21.8% YoY
|
22.90
22.14 – 23.66
+16.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tehmasp Nariman Printer | MD, Chief Executive Officer & Director | 267M | male |
| Eashwar Subramanian Iyer | Chief Financial Officer | — | male |
| Hardik Desai | Assistant GM, Company Secretary & Compliance Officer | — | male |
| Kareena Shahani | India Head - Laboratory and Operations | — | female |
| Lata Manghnani | Business Head - India | — | female |
| Siddharth Sule | Head of Global Marketing | — | male |
| Sim Woon Yong | Country Head - China | — | male |
| Sindhu Loyal | Director of Finance & Operations | — | female |
| Benaifer Palsetia | Global Chief Human Resources Officer | — | female |
| Van Es Robert | Country Head - Hong Kong & Thailand | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IGIL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
